Tilray Announces Support Of Two New Clinical Research Studies In Australia And Canada

MCRI

CANADA: Tilray, Inc., a global leader in cannabis research and production, today announced its support of two new clinical studies: a pilot study led by Murdoch Children’s Research Institute (MCRI) in Melbourne, to evaluate the feasibility and acceptability of a larger randomized placebo-controlled trial of cannabis extract as a form of treatment for reducing Severe Behavioral Problems Read the full article…

Tilray Expands Manufacturing Capacity With New Processing License From Health Canada

tilray

Newly-acquired Natura Naturals Inc. located in Leamington, Ontario obtains processing license, allowing it to produce a wide range of cannabis form factors for the Canadian market CANADA: Natura Naturals Inc., a wholly-owned subsidiary of Tilray, Inc. and High Park Holdings Ltd., has received a standard processing license under the Cannabis Act. The Natura greenhouse facility, which Read the full article…

FSD Pharma To Establish Presence In Canada’s Insurance Regimes

FSD Pharma

Signs agreement focusing on exploring insurance coverage for medical cannabis Canada wide CANADA: FSD Pharma Inc. announced the signing of a consulting agreement with Joseph L. Romano, a well-respected lawyer with a strong track-record in personal injury law. Mr. Romano has been working with medical cannabis since 2006, assisting people coping with chronic pain to have Read the full article…

Alternative Health To Launch Cannabis Extraction At 60,000 SqFt Licensed Facility In California

alternative extraction

CALIFORNIA: Alternate Health Corp., an international leader in technology solutions for the regulated cannabis industry, announced today that the Company has signed two agreements to launch operations at a state licensed 60,000 square foot cannabis extraction facility in Adelanto, California. The first agreement outlines Alternate Health’s purchase of DTS Lab Services (“DTS”), a leading cannabis extracts Read the full article…

Tilray Announces Successful Medical Cannabis Harvest In Portugal; Provides Update On European Operations

Tilray Portugal

CANADA: Tilray, a global leader in cannabis research, cultivation, production and distribution, announced that its wholly-owned subsidiary Tilray Portugal Unipessoal Lda. has completed a successful harvest of medical cannabis at the Company’s European Union (EU) Campus in Portugal. Tilray’s EU Campus in Portugal is a multi-faceted production facility that includes indoor, outdoor and greenhouse cultivation sites, Read the full article…

Aphria Receives Health Canada License Amendment, Approving Fully Expanded Production At Aphria One

Aphria

CANADA: Aphria has announced that Health Canada has granted the Company its license amendment, permitting Aphria to commence production in an additional 800,000 square feet of facilities at its Aphria One location, as part of the Company’s completed Part IV and Part V expansions. “This is a major milestone for Aphria on its path to becoming a Read the full article…

Investors That Purchased FSD Pharma Securities May Have An Opportunity To Recover Their Financial Losses.

MJLegal

CANADA: Morganti & Co., P.C., a cross border shareholder’s rights law firm, has commenced a shareholder class action lawsuit against FSD Pharma Inc. for publishing investor documents containing misrepresentations of material fact about the status of its joint venture with Auxly Cannabis Group Inc. between September 29, 2018, and January 7 or February 6, 2019. The shareholders Read the full article…

Aphria Announces Early Termination And Liquidation of Interests In Liberty Health Sciences

marijuana money

Cash proceeds of $47 million received, with additional $10 million upon satisfaction of certain conditions CANADA: Aphria announced that independent members of its Board of Directors consisting of Shlomo Bibas, John Herhalt, Tom Looney and Irwin Simon, unanimously approved the early termination and liquidation of a promissory note, option and other agreements related to the Company’s previously announced divestment Read the full article…

MediPharm Labs Signs Agreement With AusCann For Cannabis Oil Export To Australia

Medipharm

CANADA: MediPharm Labs, a leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce that its wholly-owned subsidiary, MediPharm Labs Inc. (“MediPharm Labs” or the “Company”), has entered into its first definitive international sales agreement, dated February 20, 2019, with AusCann Group Holdings Ltd. (“AusCann”) to supply private label purified, pharmaceutical Read the full article…

Tilray Increases Cannabis Supply With Acquisition Of Natura Naturals Holdings

Natura Canada

CANADA: Tilray, a global leader in cannabis research, cultivation, production and distribution, announced the closing of a previously announced definitive agreement to acquire all of the issued and outstanding securities of Natura Naturals Holdings, the parent company of a licensed cultivator of cannabis. Moving forward, the Natura facility will operate under the name High Park Read the full article…